CD14 and COVID-19: In another study, the impact of SARS-CoV-2 infection on inflammatory bowel disease was analyzed by mining GEO RNA-sequencing and single-cell RNA-sequencing datasets, highlighting an increased proportion of CD14+ monocytes in COVID-19 patients and validating 38 hub genes related to CD14+ monocytes [13].